Nevertheless, they lack effector-memory function, may be less efficient in suppressing tumor cells, and are more vulnerable to tumor rejection fatigue, suggesting that CD4+ T cells retain CD8+ T cells’ efficacy and capacity to develop into effector memory CD8+ T cells by inducing the activation and maturation of these cells [77]. The gene discussed is CD4; the disease is neoplasm.